C12Y 106/00
Oxidoreductases acting on nadh or nadph
Official title: Oxidoreductases acting on NADH or NADPH (1.6)
C12Y106/00 (Oxidoreductases acting on nadh or nadph) appears on 236 US grants and 392 published applications in this corpus.
Search patents in C12Y- Granted patents
- 236
- Published applications
- 392
- Assignees
- 209
- Inventors
- 862
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 0 |
| 2003 | 3 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 4 |
| 2009 | 0 | 6 |
| 2010 | 0 | 3 |
| 2011 | 1 | 0 |
| 2012 | 1 | 3 |
| 2013 | 2 | 7 |
| 2014 | 5 | 9 |
| 2015 | 6 | 25 |
| 2016 | 13 | 21 |
| 2017 | 14 | 35 |
| 2018 | 18 | 19 |
| 2019 | 18 | 28 |
| 2020 | 21 | 26 |
| 2021 | 31 | 35 |
| 2022 | 21 | 48 |
| 2023 | 12 | 21 |
| 2024 | 17 | 36 |
| 2025 | 28 | 26 |
| 2026 | 13 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 106/02Oxidoreductases acting on nadh or nadph: with a heme protein as acceptor102
- C12Y 106/03Oxidoreductases acting on nadh or nadph: with oxygen as acceptor42
- C12Y 106/99Oxidoreductases acting on nadh or nadph: with other acceptors41
- C12Y 106/05Oxidoreductases acting on nadh or nadph: with a quinone or similar compound33
- C12Y 106/01Oxidoreductases acting on nadh or nadph: with nad+ or nadp+ as acceptor17
- C12Y 106/06Oxidoreductases acting on nadh or nadph: with a nitrogenous group as acceptor0
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same4 Aug 2026US 12,698,517 B2Abbott Diabetes Care Inc.
- NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same21 Jul 2026US 12,686,881 B2Abbott Diabetes Care Inc.
- NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same21 Jul 2026US 12,686,882 B2Abbott Diabetes Care Inc.
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Method for producing d-talitol, d-tagatose, and d-psicose8 Oct 2026US 2026/0308649 A1Annikki GmbH
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Recombinant polypeptides for biosynthesis of thymohydroquinone (thq)10 Sep 2026US 2026/0265705 A1Epimeron USA, Inc.
- Abc transporters for the high efficiency production of rebaudiosides3 Sep 2026US 2026/0258467 A1Amyris, Inc.
Most cited
By later US patents
- Genetically modified organisms for increased microbial production of 3-hydroxypropionic acid involving an oxaloacetate alpha-decarboxylase57US 8,809,027 B1OPX Biotechnologies, Inc. · 2014
- Production of steviol glycosides in microorganisms48US 9,562,251 B2Evolva SA · 2017
- Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy34US 6,207,648 B1Trustees of Boston University · 2001
- Microbial production of natural sweeteners, diterpenoid steviol glycosides26US 9,284,570 B2Massachusetts Institute of Technology · 2016
- Efficient production of steviol glycosides in recombinant hosts19US 10,017,804 B2Evolva SA · 2018